论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
Authors Pezalla EJ, Rosen D, Erensen JG, Haddox JD, Mayne TJ
Received 6 December 2016
Accepted for publication 28 December 2016
Published 14 February 2017 Volume 2017:10 Pages 383—387
DOI http://doi.org/10.2147/JPR.S129553
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Enrica Santarcangelo
Abstract: Opioid abuse and misuse in the
USA is a public health crisis. The use of prescription opioid analgesics
increased substantially from 2002 through 2010, then plateaued and began to
decrease in 2011. This study examined prescriptions of branded and generic
immediate- and extended-release opioid analgesics from 1992 to 2016. This was
juxtaposed against state and federal policies designed to decrease
overutilization and abuse, as well as the launch of new opioid products,
including opioids with abuse-deterrent properties (OADPs). The data indicate
that these health policies, including the utilization and reimbursement of
OADPs, have coincided with decreased opioid utilization. The hypothesis that
OADPs will paradoxically increase opioid prescribing is not supported.
Keywords: OADP, prescription, utilization
trends, legislation, opioids
摘要视频链接:Opioid analgesic prescription trends